Litigation Details for IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
✉ Email this page to a colleague
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-09-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-06-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | IMPAX LABORATORIES, INC. | ||
| Patents | 7,094,427; 7,659,254; 8,377,474; 8,454,998; 8,557,283; 9,089,607; 9,089,608; 9,463,246; 9,533,046 | ||
| Attorneys | MICHAEL E. PATUNAS | ||
| Firms | Patunas Tarantino LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-05-09 | 118 | : construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler…construction of claims in U.S. Patent No. 8,377,474 (“the ’474 patent”). The Court heard oral argument…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…, “Actavis”). In this patent infringement suit involving pharmaceutical patents, the parties seek construction… It is a bedrock principle of patent law that the claims of a patent define the invention to | External link to document | |
| 2017-06-08 | 123 | limitations of the asserted claims of U.S. Patent No. 8,377,474. In the Order, the Court construed, among…U.S. Patent Nos. 8,454,998 and 9,089,607, (which are in the same patent family as the ‘474 patent and …prejudice all of its counterclaims relating to these patents, Actavis reserves its right to reassert all of … regarding the disputed limitations of the ‘474 patent claims, Impax hereby stipulates that, without waiving… Application Number 208522 do not infringe this patent as the claims are construed in the Order. 3. Moreover | External link to document | |
| 2017-06-16 | 127 | regarding the ex parte reexamination of U.S. patent No. 7,094,427, as ordered in the Court’s Order Granting…following the Patent Trial and Appeal Board Decision on Appeal. At this time, the Patent Office has not…Motion to Stay Proceedings with respect to the ‘427 patent (D.I. 47). As the Court is aware, on November 23…2015 25 June 2018 2:15-cv-06934 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
